Study on Screening Cervical Precancerous Lesions by High-risk Human Papillomavirus DNA Detection and Cytological Examination
Download as PDF
DOI: 10.25236/icbsis.2019.002
Author(s)
Lingling Tong, Xiaojun Liu
Corresponding Author
Xiaojun Liu
Abstract
Cervical cancer is one of the common malignant tumors in gynecology in China. In recent years, its incidence has increased significantly, and it has a younger trend, which seriously threatens women's physical and mental health. Clinical studies have fully confirmed that early detection and early treatment are of great value in achieving good prognosis and prolonging survival. The main link in the prevention and control of cervical cancer is the early diagnosis and treatment of precancerous lesions, blocking the potential risk of progression to cervical cancer. The key to preventing and controlling cervical cancer is early diagnosis and treatment of precancerous lesions, blocking the potential risk of progression to cervical cancer. Therefore, a reasonable and effective screening program can reduce the incidence of cervical cancer. In this study, high-risk human papillomavirus (HPV) DNA detection and cervical cytology were used. Screening for cervical precancerous lesions among women visiting gynecological clinics and taking effective measures to prevent HPV infection are undoubtedly very necessary for the prevention and treatment of cervical cancer. Screening methods for cervical cancer have also evolved from a single Histocytological level to a molecular level.
Keywords
Cervical cancer, Papillomavirus, Potential risk